Long-term persistence with aflibercept therapy among treatment-naïve patients with exudative age-related macular degeneration in a universal health care system: a retrospective study

HIGHLIGHTS

• who: Reinhard Angermann from the Department of, Medical University Innsbruck, Anichstrau00dfe, Innsbruck, Austria have published the paper: Long-term persistence with aflibercept therapy among treatment-nau00efve patients with exudative age-related macular degeneration in a universal health care system: a retrospective study, in the Journal: (JOURNAL)
• what: The authors evaluated the intrinsic and extrinsic risk factors that lead to reduced persistence to therapy among treatment-nau00efve patients with nAMD. The same study reported that the distance to the clinic was the main reason for therapy break-off in every second patient.
• how: The . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.